Download PDF
Thromb Haemost 2002; 87(06): 1081-1082
DOI: 10.1055/s-0037-1613139
Letters to the Editor
Schattauer GmbH

An Extremely Low Prevalence of Factor V Leiden, FIIG20210A and FXIIIV34L in Taiwan Chinese Population

Hong Zheng
1   Discipline of Laboratory Medicine, Department of Pathology, Chi-Mei Foundation Medical Centre, Tainan, Taiwan R.O.C
,
Tzeng Ching-Chemg
1   Discipline of Laboratory Medicine, Department of Pathology, Chi-Mei Foundation Medical Centre, Tainan, Taiwan R.O.C
,
Christopher Butt
1   Discipline of Laboratory Medicine, Department of Pathology, Chi-Mei Foundation Medical Centre, Tainan, Taiwan R.O.C
,
Edward Randell
1   Discipline of Laboratory Medicine, Department of Pathology, Chi-Mei Foundation Medical Centre, Tainan, Taiwan R.O.C
2   Discipline of Genetics, Department of Pathology, Chi-Mei Foundation Medical Centre, Tainan, Taiwan R.O.C
,
Ya-Gang Xie
1   Discipline of Laboratory Medicine, Department of Pathology, Chi-Mei Foundation Medical Centre, Tainan, Taiwan R.O.C
2   Discipline of Genetics, Department of Pathology, Chi-Mei Foundation Medical Centre, Tainan, Taiwan R.O.C
3   Discipline of Pediatrics, Memorial University of Newfoundland, St. John’s, NF, Canada; Department of Pathology, Chi-Mei Foundation Medical Centre, Tainan, Taiwan R.O.C
› Author Affiliations
Further Information

Publication History

Received 25 January 2002

Accepted 20 February 2002

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 24; 330: 517-22.
    CrossrefPubMedGoogle Scholar
  • 2 Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-7.
    CrossrefPubMedGoogle Scholar
  • 3 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
    PubMedGoogle Scholar
  • 4 Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CR. The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population. Br J Haematol 1997; 98: 353-5.
    CrossrefPubMedGoogle Scholar
  • 5 Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Jliromb Haemost 1998; 79: 8-13.
    PubMedGoogle Scholar
  • 6 Wartiovaara U, Perola M, Mikkola H, Totterman K, Savolainen V, Penttila A, Grant PJ, Tikkanen MJ, Vartiainen E, Karhunen PJ, Peltonen L, Palotie A. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 1999; 142 (02) 295-300.
    CrossrefPubMedGoogle Scholar
  • 7 Franco RF, Pazin-Filho A, Tavella MH, Simoes MV, Marin-Neto JA, Zago MA. Factor XIII val341eu and the risk of myocardial infarction. Haematologica 2000; 85: 67-71.
    PubMedGoogle Scholar
  • 8 Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
    PubMedGoogle Scholar
  • 9 Franco RF, eitsma PH, Lourenco D, Maffei FH, Morelli V, Tavella MH, Araujo AG, Piccinato CE, Zago MA. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost 1999; 08: 676-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6.
    CrossrefPubMedGoogle Scholar
  • 11 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
    CrossrefPubMedGoogle Scholar
  • 12 Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: the European burden. Br J Haematol 1999; 105: 564-6.
    CrossrefPubMedGoogle Scholar
  • 13 Gurgey A, Kudayarov DK, Tuncer M, Parlak H, Altay C. The factor V Leiden and prothrombin G20210A mutations in Kirghiz population. Thromb Haemost 2000; 84: 356.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Attie-Castro FA, Zago MA, Lavinha J, Elion J, Rodriguez-Delfin L, Guerreiro JF, Franco RF. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost 2000; 84: 601-3.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Balogh I, Szoke G, Karpati L, Wartiovaara U, Katona E, Komaromi I, Haramura G, Pfliegler G, Mikkola H, Muszbek L. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 2000; 96: 2479-86.
    PubMedGoogle Scholar
  • 16 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
    CrossrefPubMedGoogle Scholar
  • 17 Linfert DR, Rezuke WN, Tsongalis GJ. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia. Conn Med 1998; 62: 519-25.
    PubMedGoogle Scholar
  • 18 Kangsadalampai S, Board PG. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 1998; 92: 2766-70.
    PubMedGoogle Scholar